Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases
Fredrika Rajer, Lisa Allander, Philip A. Karlsson, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 6
Open Access | Times Cited: 13

Showing 13 citing articles:

Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections
Ursula Theuretzbacher, Benjamin Blasco, Maëlle Duffey, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 957-975
Closed Access | Times Cited: 39
Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance
Hervé Nicoloff, Karin Hjort, Dan I. Andersson, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
A CRISPR-Cas9 system protecting E. coli against acquisition of antibiotic resistance genes
Danna Lee, P. D. Muir, Sara Lundberg, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Metabolic state-driven nutrient-based approach to combat bacterial antibiotic resistance
Bo Peng, Hui Li, Xuan‐xian Peng
npj Antimicrobials and Resistance (2025) Vol. 3, Iss. 1
Open Access
Non-Canonical Aspects of Antibiotics and Antibiotic Resistance
Carlos F. Amábile-Cuevas, Sofia Lund-Zaina
Antibiotics (2024) Vol. 13, Iss. 6, pp. 565-565
Open Access | Times Cited: 4
Challenges and shortcomings of antibacterial discovery projects
Ursula Theuretzbacher, Enrico Baraldi, Francesco Ciabuschi, et al.
Clinical Microbiology and Infection (2022) Vol. 29, Iss. 5, pp. 610-615
Open Access | Times Cited: 18
Evaluating the innovative potential of the global antibacterial pipeline
Ursula Theuretzbacher
Clinical Microbiology and Infection (2023)
Open Access | Times Cited: 8
Harvesting and amplifying gene cassettes confers cross-resistance to critically important antibiotics
Punyawee Dulyayangkul, Thomas Beavis, Winnie W. Y. Lee, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012235-e1012235
Open Access | Times Cited: 1
Phase‐Separated Nano‐Antibiotics Enhanced Survival in Multidrug‐Resistant Escherichia coli Sepsis by Precise Periplasmic EcDsbA Targeting
Pengfei Zou, Huang Lin, Yi Li, et al.
Advanced Materials (2024) Vol. 36, Iss. 44
Closed Access | Times Cited: 1
Genetic determinants underlying the progressive phenotype of β-lactam/β-lactamase inhibitor resistance in Escherichia coli
William C. Shropshire, Hatim Amiji, Jordan Bremer, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 2
Computational and data mining studies to understand the distribution and dynamics of Temoneria (TEM) β-lactamase and their interaction with β-lactam and β-lactamase inhibitors
Priyanka Gehlot, P. Hariprasad
Environmental Pollution (2022) Vol. 314, pp. 120289-120289
Closed Access | Times Cited: 3
Genetic Determinants Underlying the Progressive Phenotype of β-lactam/β-lactamase Inhibitor Resistance inEscherichia coli
William C. Shropshire, Hatim Amiji, Jordan Bremer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Harvesting and amplifying gene cassettes confers cross-resistance to critically important antibiotics
Punyawee Dulyayangkul, Thomas Beavis, Winnie W. Y. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top